90 INTENSIVE CHEMOTHERAPY VERSUS NO INTENSIVE TREATMENT IN HIGH RISK MYELODYSPLASTYC SYNDROME (MDS) NO-HSCT CANDIDATES. (April 2015) - Bargay, J.; Xicoy, B.; Brunet, S.; Tormo, M.; Pedro, C.; Coll, R.; Talarn, C.; Marti, J.M.; Nomdedeu, M.; Font, X.; Sampol, A.; Borrás, J.; et al.